• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化和门静脉高压患者生存的预后因素。

Prognosis factors of survival in patients with liver cirrhosis and portal hypertension.

作者信息

Olevskaya E R, Dolgushina A I, Tarasov A N, Hihlova A O

机构信息

South Ural State Medical University of the Ministry of Health of the Russian Federation, Chelyabinsk, Russia.

出版信息

Ter Arkh. 2019 Mar 18;91(2):67-72. doi: 10.26442/00403660.2019.02.000089.

DOI:10.26442/00403660.2019.02.000089
PMID:31094174
Abstract

AIM

To study prognostic factors for survival in patients of liver cirrhosis (LC) with portal hypertension (PG).

MATERIALS AND METHODS

155 patients (women - 49.4%, men - 50.6%, median age 56.4 years [51.3; 61.6]) were follow up for 36 months. Viral LC was diagnosed in 33.8%, alcohol LC - 22.1%, autoimmune LC - 15.6%, other causes and cryptogenic causes noted in - 28.5%. More than half of the patients had a class В of Child-Pugh (51.9%).

RESULTS

During the study period 42 patients (28.3%) died. The analysis of survival by various factors for Kaplan-Mayer was carried out. Significant predictors: Child-Pugh class, LC etiology, comorbidity in Charlson scores, adherence to endoscopic treatment of esophageal varices were included in the model of proportional Cox risks. In a single-factor analysis, the risk of death is higher in patients who violate the timing of endoscopic treatment, but this factor has lost significance in the multifactor model. Patient with Child-Pugh C, alcoholic LC, comorbidity more 5 points by Charlson score have a higher mortality risk.

CONCLUSION

Identification of risk factors that affect the survival of LC patients will allow to use of an individual plan for the LC treatment and prevention of PG complications.

摘要

目的

研究肝硬化(LC)合并门静脉高压(PG)患者的生存预后因素。

材料与方法

对155例患者(女性占49.4%,男性占50.6%,中位年龄56.4岁[51.3;61.6])进行了36个月的随访。病毒性LC诊断率为33.8%,酒精性LC为22.1%,自身免疫性LC为15.6%,其他原因及隐源性原因占28.5%。超过半数患者为Child-Pugh B级(51.9%)。

结果

研究期间42例患者(28.3%)死亡。采用Kaplan-Mayer法对各因素的生存情况进行分析。显著预测因素:Child-Pugh分级、LC病因、Charlson评分中的合并症、食管静脉曲张内镜治疗的依从性被纳入比例Cox风险模型。单因素分析中,内镜治疗时机延误的患者死亡风险较高,但该因素在多因素模型中失去意义。Child-Pugh C级、酒精性LC、Charlson评分合并症超过5分的患者死亡风险较高。

结论

识别影响LC患者生存的危险因素将有助于制定个体化的LC治疗方案及预防PG并发症。

相似文献

1
Prognosis factors of survival in patients with liver cirrhosis and portal hypertension.肝硬化和门静脉高压患者生存的预后因素。
Ter Arkh. 2019 Mar 18;91(2):67-72. doi: 10.26442/00403660.2019.02.000089.
2
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.肝静脉压力梯度可预测代偿期肝硬化患者的临床失代偿情况。
Gastroenterology. 2007 Aug;133(2):481-8. doi: 10.1053/j.gastro.2007.05.024. Epub 2007 May 21.
3
Multicenter External Validation of Risk Stratification Criteria for Patients With Variceal Bleeding.多中心验证静脉曲张出血患者风险分层标准。
Clin Gastroenterol Hepatol. 2018 Jan;16(1):132-139.e8. doi: 10.1016/j.cgh.2017.04.042. Epub 2017 May 10.
4
[The effect of portal hypertension on prognosis in patients with decompensated liver cirrhosis].门静脉高压对失代偿期肝硬化患者预后的影响
Zhonghua Gan Zang Bing Za Zhi. 2009 Apr;17(4):263-5.
5
Clinical significance of small-bowel villous edema in patients with liver cirrhosis: A capsule endoscopy study.肝硬化患者小肠绒毛水肿的临床意义:胶囊内镜研究。
J Gastroenterol Hepatol. 2018 Apr;33(4):825-830. doi: 10.1111/jgh.14016. Epub 2018 Feb 6.
6
Survival after endoscopic sclerotherapy for esophageal varices in cirrhotics.肝硬化患者食管静脉曲张内镜硬化治疗后的生存率。
Am J Gastroenterol. 1994 Oct;89(10):1815-22.
7
Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension.吲哚菁绿滞留试验与Child-Pugh A级肝硬化合并门静脉高压患者失代偿及生存的关系
Liver Int. 2016 Sep;36(9):1313-21. doi: 10.1111/liv.13070. Epub 2016 Feb 7.
8
Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis.骨桥蛋白:门静脉高压的非侵入性参数及肝硬化的预后标志物。
World J Gastroenterol. 2016 Mar 28;22(12):3441-50. doi: 10.3748/wjg.v22.i12.3441.
9
Colorectal cancer surgery in portal hypertensive patients: does adjuvant oxaliplatin affect prognosis?门静脉高压症患者的结直肠癌手术:辅助奥沙利铂是否影响预后?
Dis Colon Rectum. 2013 May;56(5):577-85. doi: 10.1097/DCR.0b013e318286f8fc.
10
Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease.预测晚期肝病患者食管或胃静脉曲张存在的因素。
Am J Gastroenterol. 1999 Nov;94(11):3292-6. doi: 10.1111/j.1572-0241.1999.01540.x.

引用本文的文献

1
Evaluating clinical outcomes and prognosis in patients with cirrhosis and portal hypertension: a retrospective observational cohort study.评估肝硬化和门静脉高压患者的临床结局和预后:一项回顾性观察队列研究。
BMJ Open Gastroenterol. 2023 Nov 29;10(1):e001234. doi: 10.1136/bmjgast-2023-001234.
2
Hepatoprotective effects and mechanisms of Ixeris denticulate water extract on liver cirrhosis in experimental rat.齿叶橐吾水提物对实验性大鼠肝硬化的保肝作用及机制。
BMC Complement Med Ther. 2020 Jun 5;20(1):175. doi: 10.1186/s12906-020-02957-w.